Grace Therapeutics, Inc. - GRCE
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | — | P | A | 66,411.0 | 1.7679 | 117,408.01 | 3,036,411.0 | View | |
| Oct 26, 2026 | — | P | A | 21,390.0 | 1.9258 | 41,192.86 | 2,970,000.0 | View | |
| Oct 21, 2026 | — | P | A | 4,256.0 | 1.88 | 8,001.28 | 2,948,610.0 | View | |
| Oct 16, 2026 | — | P | A | 36,347.0 | 1.8917 | 68,757.62 | 2,944,354.0 | View | |
| Oct 16, 2026 | — | P | A | 23,485.0 | 1.9453 | 45,685.37 | 2,908,007.0 | View | |
| Oct 16, 2026 | — | P | A | 11,233.0 | 1.9349 | 21,734.73 | 2,884,522.0 | View | |
| Oct 13, 2026 | — | P | A | 7,215.0 | 2.02 | 14,574.3 | 2,873,289.0 | View | |
| Oct 13, 2026 | — | P | A | 5,340.0 | 2.0446 | 10,918.16 | 2,866,074.0 | View | |
| Oct 13, 2026 | — | P | A | 2,077.0 | 2.0175 | 4,190.35 | 2,860,734.0 | View | |
| Oct 05, 2026 | — | P | A | 1,694.0 | 2.06 | 3,489.64 | 2,858,657.0 | View | |
| Oct 05, 2026 | — | P | A | 20,000.0 | 2.0684 | 41,368.0 | 2,856,963.0 | View | |
| Oct 05, 2026 | — | P | A | 38,796.0 | 2.0353 | 78,961.5 | 2,836,963.0 | View | |
| Oct 01, 2026 | — | P | A | 7,849.0 | 2.09 | 16,404.41 | 2,798,167.0 | View | |
| Oct 01, 2026 | — | P | A | 5,318.0 | 2.1 | 11,167.8 | 2,790,318.0 | View | |
| Oct 01, 2026 | — | P | A | 9,771.0 | 2.1 | 20,519.1 | 2,785,000.0 | View | |
| Sep 23, 2026 | — | P | A | 5,318.0 | 2.1 | 11,167.8 | 2,855,318.0 | View | |
| Sep 23, 2026 | — | P | A | 9,771.0 | 2.1 | 20,519.1 | 2,850,000.0 | View | |
| Sep 21, 2026 | — | A | A | 12,200.0 | 0.0 | 0.0 | 12,200.0 | View | |
| Sep 21, 2026 | — | A | A | — | 0.0 | — | 12,200.0 | View | |
| Sep 21, 2026 | — | A | A | 12,200.0 | 0.0 | 0.0 | 12,200.0 | View | |
| Sep 21, 2026 | — | A | A | 12,200.0 | 0.0 | 0.0 | 12,200.0 | View | |
| Sep 10, 2026 | — | P | A | 5,836.0 | 2.0899 | 12,196.66 | 2,775,229.0 | View | |
| Sep 10, 2026 | — | P | A | 9,393.0 | 2.0972 | 19,699.0 | 2,769,393.0 | View | |
| Sep 10, 2026 | Chief Executive Officer | P | A | 100,000.0 | 2.14 | 214,000.0 | 121,357.0 | View | |
| Sep 01, 2026 | VP Program Management | A | A | 35,760.0 | 0.0 | 0.0 | 35,760.0 | View | |
| Sep 01, 2026 | Chief Executive Officer | A | A | 267,160.0 | 0.0 | 0.0 | 267,160.0 | View | |
| Sep 01, 2026 | Chief Medical Officer | A | A | 54,690.0 | 0.0 | 0.0 | 54,690.0 | View | |
| Sep 01, 2026 | Principal Financial Officer | A | A | 33,660.0 | 0.0 | 0.0 | 33,660.0 | View | |
| Aug 19, 2026 | — | P | A | 11,608.0 | 2.0853 | 24,206.16 | 2,760,000.0 | View |